Imricor Medical Systems Inc

Healthcare AU IMR


Last update at 2024-05-29T02:51:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -17.35627M -19.73254M -12.44647M -13.29398M -5.44848M
Minority interest - - - - -
Net income -17.53418M -20.55611M -13.07680M -14.79815M -5.44848M
Selling general administrative 4.98M 5.82M 4.33M 2.64M 2.29M
Selling and marketing expenses 2.80M 2.87M 1.68M 0.57M -
Gross profit -1.52678M -1.89592M -0.39767M 0.26M 1.00M
Reconciled depreciation 0.71M 0.69M 0.53M 0.26M -
Ebit -17.17835M -19.62369M -12.14584M -12.26324M -4.81724M
Ebitda -16.46586M -18.93458M -11.61775M -12.00594M -
Depreciation and amortization 0.71M 0.69M 0.53M 0.26M -
Non operating income net other - - - - -
Operating income -17.17835M -19.62369M -11.61775M -12.00594M -4.81724M
Other operating expenses 18.81M 21.74M 13.21M 13.39M -
Interest expense 0.18M 0.11M 0.30M 1.03M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.11M 0.02M 0.04M 0.80M 0.63M
Net interest income -0.06992M -0.09212M -0.35238M -1.45144M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.18M 0.82M 0.63M 1.50M -
Total revenue 0.82M 0.70M 0.70M 0.64M 1.00M
Total operating expenses 16.47M 19.15M 12.11M 13.01M 5.82M
Cost of revenue 2.34M 2.59M 1.10M 0.38M -
Total other income expense net -0.17792M -0.10885M -0.82873M -1.28803M -0.63124M
Discontinued operations - - - - -
Net income from continuing ops -17.35627M -19.73254M -16.16005M -18.97513M -5.44848M
Net income applicable to common shares -17.35627M -19.73254M -12.44647M -13.29398M -5.44848M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 12.18M 13.70M 26.86M 33.57M 10.52M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.52M 1.59M 1.51M 0.49M 0.29M
Total liab 25.00M 6.19M 4.46M 4.75M 3.49M
Total stockholder equity -12.82827M 7.51M 22.40M 28.82M 7.03M
Deferred long term liab - - - - -
Other current liab 1.16M 0.02M 0.18M 0.50M 0.39M
Common stock 0.02M 97.47M 95.01M 81.69M 47.46M
Capital stock - 97.47M 95.01M 81.69M 47.46M
Retained earnings -164.99880M -89.96098M -72.60472M -52.87218M -40.42570M
Other liab - 0.54M 0.51M 0.62M 0.59M
Good will - - - - -
Other assets - 0.23M 0.57M 0.75M 0.97M
Cash 1.22M 5.69M 18.52M 25.14M 5.05M
Cash and equivalents - - - - -
Total current liabilities 6.70M 2.07M 2.74M 2.30M 1.42M
Current deferred revenue 0.85M 0.92M 1.35M 1.07M 0.37M
Net debt 14.48M -1.19781M -16.77856M -23.75387M -4.89347M
Short term debt 1.60M 0.87M 0.52M 0.20M 0.13M
Short long term debt - - - - -
Short long term debt total 15.70M 4.49M 1.74M 1.39M 0.16M
Other stockholder equity 152.15M - - 2.14M 1.60M
Property plant equipment - 3.56M 3.60M 3.89M 2.74M
Total current assets 5.77M 9.68M 22.70M 28.92M 6.81M
Long term investments - - - - -
Net tangible assets - 7.51M 22.40M 28.82M 7.03M
Short term investments - - - - -
Net receivables 0.58M 0.13M 0.09M 0.22M 0.26M
Long term debt - 2.18M - - 0.00000M
Inventory 2.46M 2.28M 2.58M 3.07M 1.22M
Accounts payable 3.08M 0.26M 0.69M 0.53M 0.54M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -2.13881M -1.59752M
Additional paid in capital - - - - -
Common stock total equity - - - 106.06M 67.74M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.49M 0.46M 0.57M 0.75M 0.97M
Deferred long term asset charges - - - - -
Non current assets total 6.40M 4.02M 4.17M 4.64M 3.71M
Capital lease obligations - 2.31M 1.74M 1.80M 0.69M
Long term debt total - 2.25M 0.23M 0.67M 1.14M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.23886M -0.06956M -1.00498M -0.75555M -0.06956M
Change to liabilities -0.57287M 0.24M -0.29858M 0.26M -0.25280M
Total cashflows from investing activities -0.23886M -0.69530M -0.77403M -0.52934M -0.15059M
Net borrowings 1.97M -0.58130M -0.38244M 3.23M 4.74M
Total cash from financing activities 3.94M 11.59M 33.02M 10.45M 4.70M
Change to operating activities 0.11M -0.60549M 0.74M 0.18M 0.01M
Net income -17.53418M -19.73254M -12.97456M -13.55128M -5.44848M
Change in cash -12.82839M -6.62360M 20.09M 3.46M -0.18073M
Begin period cash flow 18.52M 25.14M 5.05M 1.59M -
End period cash flow 5.69M 18.52M 25.14M 5.05M 2.27M
Total cash from operating activities -16.82169M -17.48855M -12.23069M -6.62799M -4.73385M
Issuance of capital stock 4.37M 12.17M 33.41M 7.22M -
Depreciation 0.71M 0.69M 0.53M 0.26M 0.08M
Other cashflows from investing activities 0.00000M -0.06956M -0.03215M -0.16458M -0.00386M
Dividends paid - - - - -
Change to inventory -0.44497M -0.18136M -1.84930M -0.84630M -0.22640M
Change to account receivables -0.06822M 0.15M 0.07M -0.16097M 0.03M
Sale purchase of stock -0.07067M 12.17M 33.41M 7.22M 0.01M
Other cashflows from financing activities 0.51M -0.58130M -0.38244M 3.23M -0.04935M
Change to netincome 1.01M 1.94M 1.02M 2.67M 0.82M
Capital expenditures 0.24M 0.63M 0.74M 0.36M 0.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.97767M -0.38914M -1.33266M -0.56636M -0.44087M
Stock based compensation - - - - -
Other non cash items 16.82M 19.04M 11.92M 13.29M -
Free cash flow -17.06055M -18.11429M -12.97258M -6.99275M -


  • Previous Close 0.44
  • Market Cap101.43M
  • Volume241069
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-16.14746M
  • Revenue TTM0.62M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -1.52678M
  • Diluted EPS TTM-0.22

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Imricor Medical Systems Inc
0.03 6.82% 0.47 - - 176.04 4.38 199.98 -5.6287
Cochlear Ltd
-12.31 3.79% 312.61 60.26 46.30 9.75 11.76 9.62 36.63
Polynovo Ltd
0.04 1.90% 2.15 - 140.85 17.37 21.49 17.51 647.42
Anteris Technologies Ltd
-0.2 1.04% 19.00 - - 104.23 14.98 95.15 -5.9152
Avita Therapeutics Inc
0.17 6.75% 2.69 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News


Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Imricor Medical Systems Inc

400 Gateway Boulevard, Burnsville, MN, United States, 55337

Key Executives

Name Title Year Born
Mr. Steve Wedan Pres, CEO & Exec. Chairman 1969
Mr. Gregg Stenzel Chief Operating Officer NA
Mr. Jonathon Gut CFO, Controller, Director & VP of Fin. NA
Mr. Greg Englehardt Exec. Director of Sales NA
Mr. Nick Twohy VP of Marketing & Bus. Devel. NA
Mr. Kobe Lizheng Company Sec. & Local Agent NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969
Mr. Jonathon Gut CFO, Controller, Director & VP of Finance NA
Mr. Greg Englehardt Senior Director of Sales NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).